Muscle Pharm Corporation (MSLPQ)

[turokman]

According to the domestic results, Q1 really wasn't that bad compared to last year, especially if there was channel filling last year for the Arnold Series. The path to profitability is my biggest concern here, but I think they can do it with the higher margin mass market products and with the manufacturing deal. Believe it or not, I think they have the correct vision, but we will see about execution.

United States
2015 Q1 $31,588

2014 Q1 $33,000

http://www.sec.gov/Archives/edgar/data/1415684/000156459015003962/mslp-10q_20150331.htm